Regulation of insurers' use of genetic information means actuaries are interested in age-at-onset of genetic disorders. Arjas & Haara (1984) suggested marked point processes (MPPs) as useful models for life history data with complex covariates. Age-at-onset distributions (or equivalently, hazard rates) in respect of inherited disorders are often estimated from pedigrees, which are life histories with unusually complex covariates, as well as strong dependencies induced by shared genes. Since Elston (1973) parametric models have often been used, conditioning the likelihood on known genotypes. However, a genotype identified by a presymptomatic genetic test is a form of internal covariate (Kalbfleisch & Prentice, 2002) . We propose a very general MPP model of a pedigree, including presymptomatic genetic testing, ('the full model') and show under what circumstances the partial model leading to Elston's likelihood is valid. In practice, pedigrees are often ascertained retrospectively. Many such events can be modelled by augmenting the natural filtration of the MPP. We show that, except in simple special cases, the partial model is no longer valid, and the resulting likelihoods appear to be intractable. In particular, ascertainment interacts even with independent censoring so that likelihoods no longer factorize. For one simple special case -studies of sibships -we generalise a classical result to age-at-onset data. We conclude that the study of genetic conditions with variable age at onset gains insights from the underlying principles of survival analysis in their modern form, but that great care is needed in translating epidemiological studies into actuarial models.
Introduction

Survival Analysis on Pedigrees
Medical underwriting of long-term insurance contracts often must be based on the epidemiological literature. The typical study seeks to estimate onset rates of disease, and mortality rates after onset. The actuary's premium rates, based on these estimates, are then themselves point estimates, which must inherit sampling distributions depending on the data and the study design. This aspect of medical underwriting is rarely considered, in contrast to its non-life equivalent.
Genetics has forced the pace, because the furore over insurers possibly using presymptomatic genetic test results has led to this kind of information being regulated. In particular, in the U.K., the government has charged the Genetics and Insurance Committee (GAIC) with deciding when a genetic test result is so relevant to the insurance risk that it may be used in underwriting (for large risks only). The criteria adopted by GAIC, although not explicitly statistical, suggest that its decisions might be aided by understanding the sampling properties of premium rate estimates. We would expect GAIC to require, as a minimum, that premium rate estimates should be unbiased, and be reliably distinct for different genotypes. Lu, Macdonald & Waters (2008) and Lu, Macdonald & Wekwete (2008) studied the dispersion of critical illness (CI) insurance premium rate estimates. They used rates of disease onset derived from survival analyses of family histories, assuming these rates to be unbiased estimates. However, Espinosa & Macdonald (2007) showed that one of the usual assumptions made in survival analysis -that truly independent censoring does not introduce bias -does not hold if the pedigrees were sampled retrospectively, as is often the case. They considered non-parametric (Nelson-Aalen) estimation, whereas many pedigree studies use parametric (likelihood) models. Our motivation here, with actuarial applications in mind, is the question of bias in parametric survival analysis based on pedigrees.
To see why problems might arise, contrast the features of a 'normal' survival study -prospective design, independent subjects, random censoring and fixed covariates -with a typical pedigree study. Following GAIC, we focus on the presence or absence of a rare heritable gene variant that leads to disease onset in adults, and note that disease onset is the event of interest, and death a form of censoring. (a) Rarity prevents sampling of the general population, so subjects are drawn from families in which the disease has been reported. (b) At least one family member must be affected for the family to be noticed by researchers. The latter is an event, not always well defined, called 'ascertainment'. Inference should not be based on the information that led to ascertainment. Failure to exclude it leads to 'ascertainment bias'. There is a large literature on ascertainment bias and how to adjust for it (see Hodge (2002) and references therein) but little in the specific context of onset rates and survival analysis. Li (2007) is a useful reference for survival analysis in genetic epidemiology. (c) Because family members share genes, their lifetimes are dependent. (They will share environment too, but that is beyond our scope.) Likelihoods must be summed over all possible joint genotypes for the entire pedigree. After allowing for any genotypes that have been observed directly, Mendel's laws and the family structure give the probability distribution for the joint pedigree genotype. (d) The advent of DNA sequencing means that a person's genotype may be revealed by a healthy person taking a presymptomatic genetic test. The usual reason for doing so is that they have one or more affected relatives, so they are members of families more likely to be ascertained anyway. The result of any such test is an internal covariate. That is, we learn the test result because the person concerned remained free of onset up to the time of the test. This is discussed in Section 1.2. (e) Late onset means that observation of onset may be censored in the usual way. Arjas & Haara (1984) proposed marked point process (MPP) models for survival data with complicated covariates. Pedigrees with presymptomatic genetic testing fit that description, and have highly structured dependencies between lifetimes also. In any survival analysis, we hope that all complicating factors (of which the simplest is censoring) can be ignored, in the sense that while they may affect the form of the likelihood, we need only estimate those parameters related directly to the event of interest. This often amounts to using a partial model instead of a full model that includes all complicating factors. However, only by specifying the full model can we tell whether or not the use of a partial model is justified (Arjas & Haara, 1984) . Of particular interest to us is whether the method of ascertainment may interact with censoring, so that the latter cannot be ignored. Elston (1973) defined pedigree likelihoods for genetic traits with late onset, allowing rates of onset to be estimated (see Section 1.4). This work pre-dated genetic testing, hence known genotypes as (internal) covariates. It also preceded the modern point process approach to survival analysis, which is the key to testing whether the full model leads to a valid partial model.
Our aim is to formulate a MPP model of a pedigree, to address the following questions. (a) Can we recover Elston's likelihood from a properly formulated survival model? (b) How are internal covariates generated by presymptomatic genetic tests to be included in the model? (c) How does retrospective ascertainment: (i) interact with censoring; and (ii) affect estimates of onset rates?
Genetic Test Results Are Internal Covariates
Suppose a man had a presymptomatic genetic test at age 40 and was shown to carry a diseasecausing mutation. In estimating the rate of onset at age 30 (say) in a survival analysis we ask: "given that he is healthy at age 30, what is the probability that onset occurs before age 31?". Knowing the genotype, a sharper question is: "given that he is healthy at age 30 and carries a causative mutation, what is the probability that onset occurs before age 31?". But, allowing for how we learned about the genotype, we should really ask: "given that he is healthy at age 30 and a causative mutation was revealed by a presymptomatic test at age 40, what is the probability that onset occurs before age 31?", to which the answer is "zero". This is the problem of an 'internal' covariate (Kalbfleisch & Prentice, 2002) whose value is learned by observing an event which is: (a) of interest only because it reveals the covariate; but (b) not independent of the event we are studying. Worse, in a pedigree, a presymptomatic test carried out on one person will change what we know about other people's genotypes, because of Mendel's laws.
A discrete-time example (based on Arjas & Haara (1984, Section 3) ) shows how to finesse internal covariates. Denote the 'events' in a life history A 1 , A 2 , . . . , A n in order of their occurrence. They may be events of interest, 'nuisance' events like censoring, or time passing while nothing happens. Suppose a covariate takes values in a set U. If the observed covariate is v ∈ U, and the model parameter is θ, the likelihood constructed in the usual sequential way is:
from which P [v] may be dropped if the covariate distribution does not depend on θ. But how did we learn v? Strictly, we did so by observing an event C, which must be part of the model. Sometimes C is trivial, for example, if everyone is genotyped at the start of a prospective study. But if C happens at a random time it carries information about some of the A i . Suppose that A i is the event 'free of symptoms at age i' and C is the event 'had a presymptomatic genetic test at random age j with result v'. Since the test precedes onset by definition, C ⇒ A i for i ≤ j, and the sequential construction is:
It seems that we should condition on v only after it is known. However, the event C has two parts: the random age j, and the result v. Denote the first of these C j , so C = (C j , v). In MPP terms, v is a mark observed when C j occurs. The likelihoods just before and after the genetic test are:
From Bayes' Theorem: 
as if the genotype v was known at outset. Further, for k > j assume that
; then we recover the likelihood (1). In terms of Arjas & Haara (1984) these assumptions mean that the only innovative part of the genetic test was the result v. Arjas & Haara pointed out that only by investigating the full model (including the event C = (C j , v) as above) can we tell whether or not we may use a partially specified model, such as one that just conditions on v. However, the example above does not immediately suggest how to introduce internal covariates when we have dependent life histories linked by shared genes.
The Elements of a Genetic Model of Inherited Disease
Rates of onset, the focus of actuarial interest, are just one part of a genetic model of inherited disease. We assume the whole model has a parameter denoted θ. processes in the body. If one deleterious allele is sufficient to cause a disease, the disease is dominantly inherited, and can be passed on by just one parent. If two deleterious alleles are necessary, the disease is recessively inherited, and must be passed on by both parents. (c) Some diseases are purely genetic in origin, for example Huntington's disease has no known cause except mutations in the huntingtin gene. But many common diseases, such as breast or colorectal cancer, have inherited variants. (d) Even the presence of a proven 'causative' genotype does not guarantee that disease will be observed. The probability of onset by age x, given the genotype and assuming all other decrements to be absent, is called the age-related penetrance of the genotype. Penetrance at high ages may be less than 100%, and in practice other decrements introduce censoring.
Pedigree Likelihoods
Let θ be the parameter of a genetic model, defining rates of onset and mode of transmission. Let there be M genotypes, labelled from 1 to M , and N pedigree members, labelled from 1 to N . The possible joint genotypes of the pedigree are the N -tuples in the set U = {1, 2, . . . , M } N . The probability, under θ, that the pedigree genotype is u is denoted P θ [u] . Let µ g (x, θ) be the hazard of onset at age x, given genotype g. The hazard is interpreted as follows: the probability that a healthy person of genotype g and age x will suffer onset by age x + dx is µ g (x, θ)dx, for small dx. Suppose the highest age at which the jth person was observed is x * j , and give the indicator I j the value 1 if x * j was the age at onset or the value 0 if x * j was the age at censoring (we assume that observation ceases at onset). Then from Elston (1973) the likelihood is: (Elston (1973) parameterized the likelihood in terms of the lifetime penetrance, and the distribution of age at onset conditional on onset occurring. In (9), penetrance is incomplete (less than 100%) if ∞ 0 µ g (x, θ) dx < ∞, defining an improper distribution for the age at onset. Here, it will be clearer if the hazard is explicit.)
As an example, consider the pedigree in Figure 1 , in respect of a rare dominantly inherited disorder such that: (a) there are only two genotypes, 'normal' labelled 1 and 'mutation' labelled 2; and (b) the mutation is the sole cause of the disease. Let φ be the population prevalence of mutation carriers. The pedigree genotype is u = (u 1 , u 2 , u 3 , u 4 ), the indices referring to the labels in the figure. Table 1 shows the contributions to the likelihood (9) just before and just after person 4 suffers onset at age x 4 . Because the mutation is rare, we ignore the possibility that it is introduced to the pedigree by more than one Table 1 : Terms in the likelihood in respect of the pedigree in Figure 1 , before and after the person labelled '4' suffers onset at age x 4 . Wild-type alleles are labelled 1, and mutations are labelled 2.
person, so (for example) pedigree genotype (2,1,2,1) is considered infeasible. For brevity we drop θ and define the survivor functions and densities, respectively as:
Implicit in Elston's likelihood is the assumption that pedigree members' life histories are independent, conditional on the pedigree genotype. Then the likelihoods before and after the onset at age x 4 are found by summing the columns in Table 1 ; for example the likelihood just after the onset at age x 4 is proportional to:
Impossible genotypes (sufferers cannot have genotype 1) vanish whenever onset occurs because µ 1 (x, θ) = 0 for all θ, which is not the same as conditioning upon known genotypes, although it looks like it. If, instead of suffering onset, person 4 had taken a genetic test at age x 4 , we would hope to proceed by defining U * ⊂ U to be the set of pedigree genotypes consistent with known genotypes as revealed by genetic tests, then using a likelihood proportional to:
However, test results are internal covariates and, as in Section 1.2, we cannot just sum over U * instead of U, without including genetic testing in a fully specified model. Moreover, unlike most covariates in a survival model, a genetic test result can ripple through the whole pedigree, for example altering what was previously known about deceased ancestors. Our approach, in Sections 3 and 4, is to define U * (t) to be the set of pedigree genotypes consistent with all genetic test results known at time t. We show that a new member joining at time t expands U * (t − ) (just before time t) to a larger set U * (t) ⊃ U * (t − ); that a genetic test taken at time t shrinks U * (t − ) to a smaller set U * (t) ⊂ U * (t − ); and that the likelihood based on the history at time t is the sum (12) over U * (t).
Survival Analysis Based on Marked Point Processes
Marked Point Processes and Hazards
As references for this section, Andersen et al. (1993) is a standard text on survival analysis based on counting processes, while Arjas & Haara (1984) and Arjas (1989) introduce the MPP approach.
The idea of a MPP is that events happen at a sequence of random times t 1 , t 2 , . . ., and at each time t r information called a 'mark' may be obtained, for now denoted e r . Marks may convey almost any kind of information, three important examples being the following: (a) The mark e r may indicate that a specific type of event has occurred, for example a transition between two distinct states of health. Thus a multi-state or staging model is a MPP.
(b) The mark e r may indicate that an event happened to a particular person. That is, we can model the joint life histories of several people as a single MPP. This is merely cosmetic if they have mutually independent life histories, but not in the case of pedigree data. (c) The mark e r may be the value of a covariate observed at time t r , for example, the result of a presymptomatic genetic test.
We work in continuous time, and suppose that: (a) we observe persons, labelled i = 1, 2, . . ., whose life histories need not be mutually independent; and (b) any one person's life history is modelled by transitions between a finite set of states S. Then an event h is defined by the triple (i, k, l), meaning that the ith person made a transition between states k and l of S. Let H be the set of all such possible events.
Event h can happen at time t only if the ith person is in state k just before time t, which time we denote t − . Then we say the MPP is 'at risk of event h at time t − '. Define the following processes:
N h (t) = the number of occurrences of event h by time t
λ h (t) = the hazard rate of event h at time t (15)
Let F t (F t − ) denote the information obtained by observing the MPP up to and including (not including) time t. Interpret hazard rates as in Section 1.4, but allowing for
P[ Event h occurs before time t + dt | F t − and at risk of event h at time
To refer to events h = (i, k, l), we will use the compact notation λ h (t) = λ i kl (t) instead of λ (i,k,l) (t) (and similarly for Y h (t), N h (t) and A h (t)).
Likelihoods
Heuristically, given the history at time t − , the event h happens at time t with probability Y h (t)λ h (t)dt = dA h (t), or does not happen with probability 1 − dA h (t). These give the Bernoulli likelihood:
Multiplying all these terms over the interval [0, T ], in the limit, the likelihood is the product integral:
The simplest example is h = (i, 1, 2), where state 1 is 'alive' and state 2 is 'dead', and supposing the ith person was observed until time t * ; (19) is: 
Each event h ∈ H contributes a factor like (19) to the likelihood, so:
Figure 2: A model of the life history of the ith member of a pedigree, in State 1 from birth, with genotype being then unobserved. Each possible transition from State j to State k is governed by a hazard rate (intensity) λ i jk (t) depending on calendar time t.
Marks
Information, called a 'mark', may be acquired when an event h ∈ H occurs at time t. It is denoted e h (t), taking values in a suitable mark space, denoted E h (t). Let F t now include the information obtained by observing marks. Then the likelihood (21) becomes:
For brevity, we will usually write P[e h (t)] instead of P[e h (t)|F t − , dN h (t) = 1], the conditioning on the event occurring being understood.
A Marked Point Process Model of a Pedigree
Aims
We model a pedigree as a MPP with the following observable events: new members joining, disease onset, predictive (presymptomatic) genetic tests and censoring. We leave aside obvious extensions, for example to diagnostic testing after onset. We need a lot of notation, so we list the main definitions at the end of the paper.
Timescales
We need to track all pedigree members simultaneously in calendar time, so we index all processes by calendar time t, only introducing age x as needed (see Andersen et al. (1993) , Section X.1.9). Observation takes place in the interval [0, T ] of calendar time. Suppose the ith person is born at calendar time b i ; then define:
x i (t) = t − b i = the age of the ith person at calendar time t.
The Genetic Model: Genotypes and Penetrances
Let there be M genotypes, labelled 1, 2, . . . , M , and let the population frequency of genotype g be φ g . For genotype g define the hazard or intensity of onset, a function of age x, denoted as µ g (x): µ g (x) = Rate of onset at age x given genotype g.
Thus, if the ith pedigree member has (or is assumed to have) genotype g, the rate of onset to which they are subject at calendar time t, if then at risk, is µ g (x i (t)). Knowing µ g (x) is equivalent to knowing the penetrance of genotype g. Denote the parameter of the genetic model θ (so φ g and µ g (x) are part of θ), and denote the resulting probability distribution P θ .
Life Histories
The ith pedigree member's life history is represented by the states and transitions shown in Figure  2 , that is, the set of events: 1, 2), (i, 1, 3), (i, 1, 4), (i, 2, 3 ), (i, 2, 4)
and the set of events in the pedigree model is H = i H i . Note that the hazards (intensities) λ h (t) = λ i kl (t) are functions of calendar time, and they are not in general identical for different pedigree members (so the 'i' superscript in λ 
The Pedigree History
We need to add structure to express the dependencies in a pedigree. To do this, define a new event, not represented in Figure 2 , namely new members joining. This is the essential difference between modelling the pedigree and modelling the trivial collection of its members. The idea is as follows: (a) At calendar time t, the pedigree has N (t) members (alive or dead; having joined, no-one leaves). (b) Events happen at a sequence of random times t 1 , t 2 , . . .. (c) Events may be of two kinds: (i) one of the events h ∈ H defined above (an existing pedigree member experiences a transition); or (ii) one or more new members join the pedigree, either by birth or by marriage. More than one new member may join only in the case of a multiple birth.
Augment H with a new event labelled '0', which is 'one or more persons join the pedigree': define H * = {0} ∪ H. Joiners may be 'founders', meaning original members or spouses of members, or 'births', meaning children born to existing members. Let N 0 (t) be the number of joining events by time t (note that N 0 (t) ≤ N (t)) and let λ 0 (t) be the associated intensity. With each joining event, associate a mark e 0 (t) that carries all the information that may be needed. For births, this must identify the parents, and siblings in the case of multiple births. For marriages, it should include sex, the age t − b i on joining the pedigree, and which state in Figure 2 was entered upon joining. The intensity λ 0 (t) will be a function of the numbers and ages of all potential child-bearing couples in the pedigree, and possibly extra information known at time t − as well. Any likelihood from which λ 0 (t) cannot be dropped will almost certainly be intractable, but we need to specify a full model before seeing what can be omitted in a partial model.
For simplicity, we suppose that joiners enter State 1 in Figure 2 . This is realistic in the case of births, and can easily be relaxed for spouses joining the pedigree.
Pedigree Genotypes
We invent a 'null' genotype labelled 0 to which members not yet in the pedigree are assigned. (a) Let U(t) be the set of all possible pedigree genotypes at time t. That is, the set of all u = (u 1 , u 2 , . . . , u N (t) , 0, 0, . . .), where each u i ∈ {1, 2, . . . , M } for i ≤ N (t). (b) Also, let U * (t) be the set of all possible pedigree genotypes allowing for any members whose genotype is known because of a genetic test taken not later than time t. For example, if the 1st pedigree member has been tested before time t and has genotype v 1 , then U * (t) ⊆ {u ∈ U(t) :
3.7 Observation and Information (a) The information known at time t from observing the pedigree history is denoted F t . (b) The information known at time t solely from knowing the pedigree structure (that part of the 'joining' marks e 0 (t) identifying parents and identical siblings) is denoted A t .
Genotype Probabilities
We define two sets of genotype probabilities: those conditioned on the pedigree structure alone (A t ) and those conditioned on all observations (F t ). (a) Define the genotype probability at time t conditional on the pedigree structure at time t to be:
To define genotype transmission probabilities, suppose the ith member joins at time t, and let u ′ be elements of U(t − ). The transmission probability, denoted p i u , is as follows:
where
. If the ith member is a founder, p i u = φ ui . Otherwise, if e 0 (t) identifies the f th member as his/her father and the mth member as his/her mother, p i u is the probability that a father with genotype u f and a mother with genotype u m have a child with genotype u i . (b) Define the pedigree genotype probability at time t conditional on all that is known then to be:
The corresponding probability that the ith member has genotype g ∈ {1, 2, . . . , M } we define as:
Rates of Onset in Calendar Time
It is clear that λ i 23 (t) = µ g (x i (t)), where g is the known genotype, and it is easily shown that the λ i 13 (t) are averages of the µ g (x i (t)), weighted by the genotype probabilities just defined:
3.10 Likelihoods Our problem can now be stated. Elston's likelihood (9) is defined in terms of age-related onset rates and genotype probabilities as in Section 3.8(a) above, conditioned on A T , the ultimate pedigree structure at time T . Also, it does not allow for genetic testing as an internal covariate. The likelihood obtained from the survival model, set out in (30) below, is stated in terms of intensities in calendar time, and genotype probabilities must be conditioned on F t , all history up to time t, as in Section 3.8(b) above. We need to show that they are equivalent.
Elston's Likelihood
Definitions and Notation
The likelihood, in terms of the calendar-time intensities λ i jk (t), is:
assuming random sampling of the first member. We now show that this is proportional to the likelihood (12), extending Elston's likelihood (9) allowing for genetic tests. In this section, we suppose that λ i 13 (t) and λ i 23 (t) are the only intensities depending on genotype or θ, and drop other intensities from the likelihood whenever they appear as factors. Define:
to indicate all those at risk of onset just before time t.
We will often use sums over all feasible pedigree genotypes, such that the ith person's genotype v i is fixed, u∈U * (t):ui=vi , so for brevity let ui=vi represent this sum.
Sequential Construction of L(θ; T )
We will construct L(θ; T ) sequentially, conditioning the probabilities of events in each time increment on the past. Heuristically:
The key point is that:
so:
and:
We must show that whatever is observed at time t -joining the pedigree, cases of onset, genetic tests, deaths or censored observations -and during periods between events, this happens in such a way that (30) always has the form of Elston's likelihood. We suppose the pedigree genotype at time 0 − is (0, 0, 0, . . .), the only element of U * (0 − ), so:
Contributions From New Members Joining
Next, suppose the ith member joins at time t (so N (t) = i) and assume, in inductive fashion, that L(θ; t − ) is as in (32), the sum being over u ′ ∈ U * (t − ). We have:
The ith member may be a founder (a spouse marrying into the pedigree) assumed to join at some age x i (t) > 0 or a non-founder (an offspring of pedigree members) who joins at age 0. If the ith member is a non-founder we assume that P[e 0 (t)] does not involve θ and:
where: (a) the sum over u i in (37) is identically 1; (b) we note that
. If the ith member is a founder (recall that they enter state 1) then the mark e 0 (t) is their life history so far, so: (40) which is the probability that onset has not occurred by age x i (t), so p i u in (38) is replaced by:
The first member joining at time t = 0 is a special case. Also, the above is easily extended to multiple births, with N (t) − N (t − ) > 1.
Contributions From Periods With No Events
Suppose there is an event at time t * , and then no event between time t * and t. Noting that R s = R t for t * < s ≤ t, the relevant factors of the likelihood during (t * , t] can be written:
For t * < s ≤ t the genotype probabilities evolve as follows (Bayes' Theorem):
Substitute this and (29) into (42), and the contribution is:
(Note that if the ith member has had a genetic test by time t * , their genotype is known, fixed as g i , say; all genotype probabilities m u (t * ) inconsistent with this vanish, so the numerators and denominators in the integrals above are equal; and the integrand reduces to µ gi (x i (s)).) Therefore, from (33), and making age instead of calendar time the variable of integration:
That is, between jumps, each member currently at risk of onset survives free of onset and contributes the probability of that event to the likelihood.
Contributions From Cases of Onset
If the ith member suffers onset at time t, L(θ; t) is:
Applying (34), and noting that U * (t) = U * (t − ), this is:
(This is where the definition of U * (t) in terms only of information gained from genetic tests matters.) Note that if either: (a) the ith member had previously had a genetic test; or (b) the disease has no cause except a single gene mutation; then the sum in (47) has only one non-zero term.
Contributions From Genetic Tests
If the ith member has a genetic test at time t, revealing their genotype to be v i , then:
Dropping λ i 12 (t) (compare with Section 1.2, just after (7), where we assumed that the probability of being tested does not depend on θ) and applying (34):
Contributions From Deaths and Censored Observations
Following death or loss to observation at time t, no further contributions are made to the likelihood.
Constructing the Likelihood
Let x * i (T ) represent the highest age at which the ith member has been observed alive and asymptomatic up to and including calendar time T . Starting with (35), applying (46) between events, and (38), (48) or (50) when an event other than censoring occurs, L(θ, T ) is:
To within factors not depending on θ, this is the likelihood (12). It extends Elston's likelihood (9) allowing for genetic tests, and, despite appearances, we have not conditioned upon genotypes known at time T , as indeed we may not within the framework of survival analysis.
Retrospective Studies
Retrospective Studies, and Distorted Intensities and Probabilities
The model does not reflect the way in which real pedigrees are observed. Usually, 'interesting' families are identified (ascertained) through one or more affected members, often called probands, and the pedigree is extended from them using medical records and/or examinations. In other words, pedigrees are not randomly sampled, they are selected because certain events have occurred. For the large literature on ascertainment bias see Cannings & Thompson (1977) and Hodge (2002) .
There is not much literature on ascertainment bias in the context of survival models, see Li (2007) . The construction of the likelihood (51) showed the essential rôle of time, and the need to work with a fully specified model. We now show that the fully specified model gives insight into the problem of ascertainment 'after the event'.
In Sections 3 and 4, it was clear what 'the' pedigree meant, namely that pedigree evolving forwards in time from a founding member. When ascertainment is retrospective, it is less clear what 'the' pedigree means, unless there are uniform rules about who is to be included in the pedigree, starting with those persons who directly caused 'it' to be ascertained. One simple rule, which we shall use for an example, is to limit each pedigree sampled to a single nuclear family, or to a sibship (all the children in a nuclear family). Cannings & Thompson (1977) gave more flexible rules in the form of sequential procedures.
Suppose the MPP representing a given pedigree is observed if and only if an event W occurs. Then the observed pedigree history is G t = F t ∨ W , and the observed process is the MPP with 'distorted' intensities denoted asλ h (t, e) (h ∈ H * ), (note that this is the only point at which we have needed to include the mark e in the intensity) and genotype probabilities denoted asm
(This is along the same lines as Hoem (1969) and Aalen et al. (1980) , who considered Markov processes, and also the distortion of counting process intensities in retrospective studies in Langholz et al. (1999) .) Denote the fraction in (52) D h (t). If D h (t) > 1 (D h (t) < 1) then the event h makes W more (less) likely, hence the pedigree more (less) likely to be observed. Only if D h (t) = 1 does the event h not matter. This could happen if W occurred before time t, in which case, omitting all observations before W occurred would give a partial likelihood.
Likelihoods
The likelihood is the probability of the process observed, as follows:
In Section 4, we discarded nuisance parameters whenever an intensity or a mark probability not depending on θ appeared as a factor. Now, when we construct the likelihood sequentially, it is the distorted intensities and probabilities that appear as factors. These can be discarded only if the relevant D h (t) are rather simple: for example, if the ith member has a genetic test at time t, we can discard factorλ i 12 (t) from the likelihood only if D i 12 (t) does not involve the onset intensities λ j 13 (t) and λ j 23 (t) in respect of any pedigree member. This will not often be the case.
The very titles of papers by epidemiologists, such as Elston (1995) or Vieland & Hodge (1995) , tell us that retrospective ascertainment of pedigrees is difficult. Properly designed studies are strongly advocated, but in their absence the data that are to hand will be analysed, often with some approximate adjustment for ascertainment bias. Actuaries have to use caution when applying these results to questions of insurance pricing; for example, Macdonald, Waters & Wekwete (2003) reduced published onset rates of breast and ovarian cancer associated with BRCA1 and BRCA2 mutations by 50% and 75%, to allow for possible unquantified ascertainment bias.
The discussion above shows that it would be very hard, at best, to estimate onset rates when retrospective ascertainment introduced distortions D h (t), different for every event in the pedigree history. From (52), the distortions affect anyone who could have led to the ascertainment, not just those who actually did. However, we can still gain insight from simple special cases.
Application to Sibships
Sibships are the classic units of analysis in genetic studies. Ascertainment through probands is allowed for by conditioning on the fact of ascertainment (Fisher, 1934; Morton, 1959) . Adapting the notation from George & Elston (1991) slightly, a sibship is characterised by three quantities: the number of siblings c, the number of affected siblings a, and the number of probands z (c ≥ a ≥ z). The simplest ascertainment model is that we include a sibship in the study if it has at least one proband, z ≥ 1. If P ′ [c] is the distribution of sibship sizes, then:
If any sibling is affected with probability ζ, and any affected sibling becomes a proband with probability π (hence the name 'π-model'), and if P[z|c, a] = P[z|a], this has the explicit form:
Two special cases are often considered: (a) 'complete ascertainment' when π = 1, so all affected members become probands; and (b) 'single ascertainment' when π → 0, so the probability of a sibship having more than one proband vanishes. The corresponding scheme in our model is that the number of members of the pedigree at time T is c + 2 (c siblings and the parents). The parents are the 1st and 2nd members, and the siblings are the 3rd and subsequent members. Suppose the disease of interest is rare, dominant and has late onset, so that no sibling will suffer onset before the sibship is complete. Then, for sibling i, λ i 13 (t) = 0 before the sibship is complete, while afterwards c is known and part of F t − , so in (52) we can condition on known sibship size. The simplest set-up is as follows. (a) One parent is identified as a mutation carrier before the siblings are at risk. (b) There is no genetic testing and no censoring (not even death). (c) Any affected member becomes a proband with probability π, and ascertainment depends on there being at least one proband at time T .
Because of (a), the siblings' life histories are (conditionally) independent, and genotype probabilities are undistorted (m u (t) = m u (t)). Because of (b), genotype will not be revealed before onset. Because of (c), the event W is 'at least one proband, alive or dead, at time T '. Let R t = {i : Y i 1 (t) = 1} be the set of siblings still at risk of onset at time t, and suppose a(t) members are affected at time t. If ascertainment fails to take place through these affected members, which has probability, (1 − π) a(t) , it must occur through one or more of the siblings in R t suffering onset in the future and then becoming a proband. So for i ∈ R t :
The likelihood (54) with these distortion factors could be maximised numerically. Under complete ascertainment (π = 1) D i 13 (t) = 1 if a(t) > 0, because ascertainment is guaranteed, and if a(t) = 0, the limit of (57) as π → 1 gives:
Under single ascertainment (π → 0) both numerator and denominator of (57) become zero, but l'Hopital's rule gives:
Under single ascertainment in the classical π-model, the probability that a sibship is ascertained is proportional to the number of affected siblings. The numerator and denominator of (59) are the expected numbers of affected siblings at time T , if a(t) + 1 or a(t), respectively, are affected at time t, which we see is the corresponding property for age-at-onset data. Figure 3 shows how the sibship size affects the distortion of the age-related penetrance under single ascertainment. The true rate of onset is Gompertz, with µ 2 (x) = 0.000814 exp(0.086178x). This results in actual penetrance of about 0.5 at age 50 among mutation carriers. Assuming the disorder to be rare and dominant, the penetrance in respect of siblings who are mutation carriers with probability 1/2 will approach 0.5 as age x → ∞. The true penetrance is shown labelled 'No Distortion' and for comparison, the penetrance 1− [0,x] 1−dλ i 13 (s) , assuming that T = 70 in (59), for sibships of size 2 to 7 (all siblings the same age, for simplicity) and for different numbers of affected siblings. The distorted penetrance is always overstated, and by more for smaller sibships.
If censoring (but not genetic testing) is introduced, with intensityλ and, since if censoring occurs the person concerned will not be available as a proband, D i 14 (t) is the same as D i 13 (t) but with the a(t) + 1 replaced by a(t) whenever it appears in the numerator. Figure 4 shows the effect of adding censoring at rate λ i 14 (t) = 0.01 per year to the previous example. Comparing this with Figure 3 it is clear that the results are identical at x = 70 (as they must be) but that censoring increases slightly the observed penetrances at younger ages.
If we introduce genetic testing in the absence of censoring, we must distinguish between persons in States 1 and 2, : let
where: We have answered the first two of these, by specifying a full MPP model of an entire pedigree, in the spirit of Arjas & Haara (1984) . By constructing the likelihood sequentially in calendar time, we recovered Elston's likelihood, genetic tests included, showing: (a) that it is correct to use the partial model upon which it is based; and (b) the apparent conditioning on known genotypes revealed by genetic testsproblematic because they are internal covariates -in fact does not occur provided the full model is used.
If sampling is retrospective and non-random, the observed process, hence the likelihood, is generated by distorted versions of the 'true' transition intensities. We observed the following: (a) In general, the distorted intensities are functions of time (hence age) and are different for each member of the pedigree. (b) The distortion factors are functions of the transition intensities we are trying to estimate. (c) We gave some examples of distorted onset intensities in the simplest setting (sibships), showing that nuisance parameters would not factorise out of the likelihood as before. Therefore, the partial model cannot be used correctly in this setting. (d) We found no obvious way to adjust the likelihood to account for this, so intimately conjoined were the true rates of onset and the factors distorting them. (e) We found in (59) and, more generally, (66), the age-at-onset counterparts for the well-known result that, under single ascertainment of sibships, the probability of ascertainment is proportional to the number of affected siblings. This appears to be a new result. (f) In particular, the popular adjustment of 'omit the proband(s)' had no justification here. This tends to support the views of those genetic epidemiologists who have described the ascertainment problem as intractable; see Vieland & Hodge (1995) . Our model shows that the special rôle of time in survival analysis introduces new problems in respect of pedigree data.
What should be done by the actuary who wishes to apply epidemiological studies to pricing, reserving and adverse selection problems? Or the regulator, who needs to test the evidence base for differential pricing? Retrospective studies are likely to yield onset rates with an unknown degree of ascertainment bias. This will be true of non-genetic studies as well as pedigree analyses. (This is, of course, the very reason why retrospective data are so often analysed by case-control studies; the estimated odds ratio is unbiased. Unfortunately, onset rates are of much more use to actuaries.) We can only conclude that actuaries must highlight the possible lack of robustness in such models, and even quite crude sensitivity tests (such as the arbitrary reductions in onset rates in Macdonald, Waters & Wekwete (2003) ) might be advisable. It is then up to assessors, such as GAIC in the UK, to judge the evidence.
